ribavirin has been researched along with Anemia, Sickle Cell in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El Agheb, MO; Grange, JD | 1 |
| Amiot, X; Ancel, D; Chaslin-Ferbus, D; Garioud, A; Girot, R; Grange, JD; Hagege, I; Pol, S | 1 |
| Abbas, FA; Ayyub, MA; El-Moursy, SA; Khazindar, AM | 1 |
| Alavian, SM; Ayyub, M; Tabatabaei, SV | 1 |
| Alavian, SM; Tabatabaei, SV | 1 |
| Inati, A; Musallam, KM; Sharara, AI; Taher, AT | 1 |
| Banks, A; Castro, O; Giday, S; Hasan, S; Hassan, M; Smoot, D | 1 |
| Smoot, DT | 1 |
| Agarwal, S; Rosse, WF; Swaim, MW | 1 |
1 review(s) available for ribavirin and Anemia, Sickle Cell
| Article | Year |
|---|---|
HCV in sickle cell disease.
Topics: Anemia, Sickle Cell; Antiviral Agents; Chronic Disease; Comorbidity; Disease Progression; Genotype; Hepacivirus; Hepatitis C; Humans; Interferons; Liver; Prevalence; Ribavirin; Transfusion Reaction; United States | 2003 |
8 other study(ies) available for ribavirin and Anemia, Sickle Cell
| Article | Year |
|---|---|
[Evaluation of tolerance and efficacy of the treatment of chronic viral hepatitis C in homozygous sickle cell patients].
Topics: Adult; Anemia, Sickle Cell; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferons; Male; Ribavirin; Treatment Outcome | 2015 |
Treatment of chronic hepatitis C in sickle cell disease and thalassaemic patients with interferon and ribavirin.
Topics: Adolescent; Adult; Anemia, Hemolytic; Anemia, Sickle Cell; Antiviral Agents; beta-Thalassemia; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Male; Pilot Projects; Ribavirin; Treatment Outcome; Young Adult | 2009 |
Successful treatment of chronic hepatitis C virus infection with peginterferon alpha-2a and ribavirin in patients with sickle cell disease.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Young Adult | 2009 |
Outcome of combination antiviral therapy in hepatitis C virus infected patients with sickle cell disease.
Topics: Anemia, Sickle Cell; Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Ribavirin | 2009 |
Treatment outcome of chronic hepatitis C in sickle cell disease and thalassemic patients with interferon and ribavirin.
Topics: Anemia, Sickle Cell; Antiviral Agents; beta-Thalassemia; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferons; Ribavirin; Treatment Outcome | 2010 |
The role of liver iron in hepatitis C antiviral treatment.
Topics: Anemia, Sickle Cell; Antiviral Agents; beta-Thalassemia; Blood Transfusion; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Iron; Liver; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2010 |
Response to "Hepatitis C virus, sickle cell disease treatment options"--a February letter to the editor.
Topics: Anemia, Sickle Cell; Antiviral Agents; Comorbidity; Hepatitis C; Humans; Interferons; Iron Chelating Agents; Ribavirin | 2004 |
Successful treatment of hepatitis C in sickle-cell disease.
Topics: Adult; Anemia, Sickle Cell; Antisickling Agents; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C; Humans; Hydroxyurea; Interferon alpha-2; Interferon-alpha; Middle Aged; Recombinant Proteins; Ribavirin | 2000 |